rheumatoid arthritis Clinical Trials and Research
Also known as: ra, chronic inflammatory arthritis, autoimmune arthritis, rheumatoid disease, inflammatory polyarthritis · ICD-10: M05-M06
Rheumatoid arthritis (RA) is a chronic autoimmune disease where the body's immune system mistakenly attacks its own joints, causing pain, swelling, and potential damage. Clinical trial research aims to find new ways to manage symptoms, slow disease progression, and improve quality of life. Find a Trial helps patients search for active studies.
Search rheumatoid arthritis trials →
Common questions about rheumatoid arthritis clinical trials
Who can participate in rheumatoid arthritis clinical trials?
Eligibility criteria vary by study, often based on age, disease severity, previous treatments, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data. Information is available on ClinicalTrials.gov.
What are the different phases of clinical trials for rheumatoid arthritis?
Clinical trials typically progress through phases, from early safety testing (Phase 1) to evaluating effectiveness and side effects (Phase 2 and 3) in larger groups. Phase 4 studies monitor long-term outcomes after a treatment is approved. Data is often found on ClinicalTrials.gov.
Do clinical trials for rheumatoid arthritis cost money to participate?
Generally, study-related medical care, tests, and sometimes travel are covered by the trial sponsor. Participants should always confirm what costs, if any, they might incur before joining a study. This information is detailed in the informed consent document.
What new treatments are being studied for rheumatoid arthritis?
Current research explores novel biologic and small molecule drugs, cell-based therapies, and personalized medicine approaches to target specific disease pathways. Studies also investigate non-drug interventions and strategies to prevent disease progression. This data is often found on ClinicalTrials.gov and NIH RePORTER.
What types of interventions are common in rheumatoid arthritis clinical trials?
Interventions range from new oral medications and injectable biologic therapies to lifestyle modifications, physical therapy, and surgical techniques. Some trials compare new treatments to existing standard-of-care options. Information on specific interventions is available on ClinicalTrials.gov.
Are there specific biomarkers being studied in rheumatoid arthritis research?
Researchers are investigating various biomarkers, including genetic markers, autoantibodies like rheumatoid factor (RF) and anti-CCP, and inflammatory proteins. These help predict disease progression, treatment response, and identify patient subgroups. Data is often found on ClinicalTrials.gov and NIH RePORTER.
What are common reasons someone might not be eligible for an RA trial?
Common exclusion criteria include certain co-existing medical conditions, pregnancy, active infections, or prior unsuccessful treatment with specific study drugs. These criteria protect participants and ensure study results are clear. Eligibility details are listed on ClinicalTrials.gov.
How do clinical trials aim to improve the daily lives of people with RA?
Trials seek to reduce pain and inflammation, prevent joint damage, improve physical function, and enhance overall quality of life. Researchers also study ways to minimize side effects and personalize treatment plans. This research is often detailed on ClinicalTrials.gov and NIH RePORTER.
How to find a rheumatoid arthritis trial that fits you
- Describe your rheumatoid arthritis situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all rheumatoid arthritis trials →